Skip to content

DNTH

Dianthus Therapeutics, Inc.

Stock

$88.21−0.11 (−0.12%)Close Oct 2, 2026

Operating income, 2025
−$178M

Operating income

Operating income by fiscal year

PeriodOperating incomeYoY
2025−$178M—
2024−$102M—
2023−$48M—
2022−$30M—
2021−$75M—
2020−$79M—
2019−$83M—
2018−$60M—
2017−$36M—
2016−$9.3M—